N-(4-(tert-butyl)benzyl)-8-imino-4-methyl-2-oxo-2H,8Hpyrano[2,3-f]chromene-9-carboxamide

ID: ALA3746269

Chembl Id: CHEMBL3746269

PubChem CID: 121238088

Max Phase: Preclinical

Molecular Formula: C25H24N2O4

Molecular Weight: 416.48

Molecule Type: Small molecule

Associated Items:

Names and Identifiers

Canonical SMILES:  Cc1cc(=O)oc2c1ccc1oc(=N)c(C(=O)NCc3ccc(C(C)(C)C)cc3)cc12

Standard InChI:  InChI=1S/C25H24N2O4/c1-14-11-21(28)31-22-17(14)9-10-20-18(22)12-19(23(26)30-20)24(29)27-13-15-5-7-16(8-6-15)25(2,3)4/h5-12,26H,13H2,1-4H3,(H,27,29)

Standard InChI Key:  UMTKCFJRDJJORY-UHFFFAOYSA-N

Alternative Forms

  1. Parent:

    ALA3746269

    ---

Associated Targets(Human)

SK-N-SH (1499 Activities)
Activity TypeRelationActivity valueUnitsAction TypeJournalPubMed IddoiAssay Aladdin ID

Associated Targets(non-human)

BCHE Cholinesterase (8742 Activities)
Activity TypeRelationActivity valueUnitsAction TypeJournalPubMed IddoiAssay Aladdin ID
ache Acetylcholinesterase (12221 Activities)
Activity TypeRelationActivity valueUnitsAction TypeJournalPubMed IddoiAssay Aladdin ID

Molecule Features

Natural Product: NoOral: NoChemical Probe: NoParenteral: No
Molecule Type: Small moleculeTopical: NoFirst In Class: NoBlack Box: No
Chirality: NoAvailability: NoProdrug: No

Drug Indications

MESH IDMESH Heading EFO IDsEFO TermsMax Phase for IndicationReferences

Mechanisms of Action

Mechanism of ActionAction Typetarget IDTarget NameTarget TypeTarget OrganismBinding Site NameReferences

Calculated Properties

Molecular Weight: 416.48Molecular Weight (Monoisotopic): 416.1736AlogP: 4.55#Rotatable Bonds: 3
Polar Surface Area: 96.30Molecular Species: NEUTRALHBA: 5HBD: 2
#RO5 Violations: 0HBA (Lipinski): 6HBD (Lipinski): 2#RO5 Violations (Lipinski): 0
CX Acidic pKa: CX Basic pKa: 4.48CX LogP: 4.18CX LogD: 4.18
Aromatic Rings: 4Heavy Atoms: 31QED Weighted: 0.38Np Likeness Score: -0.68

References

1. Shaik JB, Palaka BK, Penumala M, Kotapati KV, Devineni SR, Eadlapalli S, Darla MM, Ampasala DR, Vadde R, Amooru GD..  (2016)  Synthesis, pharmacological assessment, molecular modeling and in silico studies of fused tricyclic coumarin derivatives as a new family of multifunctional anti-Alzheimer agents.,  107  [PMID:26588065] [10.1016/j.ejmech.2015.10.046]

Source